Burkholderia Cepacia Complex (Bcc), USP <60> of non-Sterile dry products and raw materials

Reliable USP <60> testing for Burkholderia cepacia complex detection in non-sterile products and raw materials, ensuring microbiological safety, quality compliance, and regulatory confidence.

Overview Service

Capzer Pharma provides Burkholderia cepacia Complex (Bcc) Testing in accordance with USP <60> for non-sterile dry products, raw materials, and pharmaceutical ingredients. Our microbiology laboratory helps manufacturers detect the presence of objectionable microorganisms and maintain compliance with global quality and safety requirements.

Our Approach

Using validated USP <60> methodologies, selective enrichment media, and confirmatory identification techniques, our experts perform sensitive Bcc detection studies. Every test is conducted under controlled laboratory conditions with strict quality standards to ensure accurate, reliable, and regulatory-compliant results.

Key Capabilities

USP Burkholderia cepacia Complex Testing
Non-Sterile Dry Product Analysis
Raw Material Microbiological Screening
Selective Enrichment and Isolation Methods
Confirmatory Identification of Bcc Organisms
Regulatory-Compliant Documentation & Reporting

Benefits for Partners

Capzer Pharma supports manufacturers in identifying potential contamination risks early, protecting product quality and patient safety. Our dependable Bcc testing services help meet regulatory expectations, strengthen quality assurance programs, and facilitate confident product release decisions.

Other Service

Need for help?

Our expert team is here to support you with reliable pharmaceutical testing, analytical solutions, and regulatory guidance. Whether you have a query or need a customized service, we’re ready to assist you at every step.